A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Updates in Precision Medicine: Pharmacogenomics and Pharmacovigilance Conference Wednesday, September 28 – Thursday, September 29, 2022 | Orlando, FL & Online This conference, co-hosted by the University of Florida College […]
Wednesday, September 28-Thursday, September 29 | 1-5pm ET | Virtual The theme of this year’s Midwest Genetics Network (MGN) virtual Annual Meeting is “Raising the Bar: Building Authentic Relationships”. Over […]
Thursday, September 29 | 9 am EST | Virtual This webinar will be presented by Dr. Nahla Maher Afifi. The title of her talk is “Qatar Biobank: A Pillar in […]
From All of Us Research to All of Us in the Real World: Using the All of Us Research Program Data to Improve Population Health Thursday, September 29 | 9:30-11 […]
Thursday, September 29, 2022 | 3 - 4:15 p.m. ET | Virtual Beginning September 2022, NHGRI will host a new seminar series based on its Genomic Innovator Award Program, which supports […]
GMKB